You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-RNase L antibody [2E9] (ab13825)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-RNase L antibody [2E9]
See all RNase L products (3) ...

Description

Mouse monoclonal [2E9] to RNase L

Tested applications

ELISA, WB, IP, ICC, IF, IHC-P, IHC-Fr, Flow Cytmore details

Cross reactivity

Reacts with

Human, African Green Monkey, Chinese Hamster

Does not react with

Mouse

Immunogen

FPLC purified recombinant full length RNase L protein (Human) produced in insect cells.

Positive control

PC3 cells.

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: 0.01% Sodium Azide
Constituents: PBS

Concentration

Concentration information loading...

Purity

IgG fraction

Clonality

Monoclonal

Clone number

2E9

Myeloma

Sp2/0-Ag14

Isotype

IgG1

Light chain type

kappa

  • Western blot - Anti-RNase L antibody [2E9] (ab13825)Western blot - Anti-RNase L antibody [2E9] (ab13825) image (enlarge)

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-RNase L antibody [2E9](ab13825)Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-RNase L antibody [2E9](ab13825) image (enlarge)

  • Immunocytochemistry/ Immunofluorescence - Anti-RNase L antibody [2E9] (ab13825)Immunocytochemistry/ Immunofluorescence - Anti-RNase L antibody [2E9] (ab13825) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab13825 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Relevance

RNAse L is an endoribonuclease. It is a mediator of interferon action, which play a role in mediating resistance to virus infection and apoptosis. Might play a central role in the regulation of mRNA turnover (referenced from swissprot).

Cellular localization

Cytoplasmic and Mitochondrial.

Alternative names

  • 2 5A dependent ribonuclease antibody
  • 2' 5' oligoisoadenylate synthetase dependent antibody
  • 2-5A-dependent RNase antibody
  • DKFZp781D08126 antibody
  • Interferon induced 2 5A dependent RNase antibody
  • MGC104972 antibody
  • MGC133329 antibody
  • PRCA 1 antibody
  • PRCA1 antibody
  • Ribonuclease 4 antibody
  • Ribonuclease L (2' 5'-oligoisoadenylate synthetase dependent) antibody
  • Ribonuclease L antibody
  • Ribonuclease4 antibody
  • RibonucleaseL antibody
  • RNASEL antibody
  • RNS 4 antibody
  • RNS4 antibody
see all

Anti-RNase L antibody [2E9] images:

  Western blot - Anti-RNase L antibody [2E9] (ab13825)

Western blot - Anti-RNase L antibody [2E9] (ab13825)



Predicted band size : 84 kDa

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-RNase L antibody [2E9](ab13825)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-RNase L antibody [2E9](ab13825)

ab13825 (4µg/ml) staining RNASE L in human pancreas, using an automated system (DAKO Autostainer Plus). Using this protocol there is strong cytoplasmic staining.
Sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffer citrate pH6.1 in a DAKO PT link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that, for manual staining, optimization of primary antibody concentration and incubation time is recommended. Signal amplification may be required.

  Immunocytochemistry/ Immunofluorescence - Anti-RNase L antibody [2E9] (ab13825)

Immunocytochemistry/ Immunofluorescence - Anti-RNase L antibody [2E9] (ab13825)

ICC/IF image of ab13825 stained HeLa cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab13825, 5µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

  Flow Cytometry-Anti-RNase L antibody [2E9](ab13825)

Flow Cytometry-Anti-RNase L antibody [2E9](ab13825)

Overlay histogram showing HeLa cells stained with ab13825 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated inn 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab13825, 1µg/1x106 cells) for 30 min at 22ºC. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22ºC. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2µg/1x106 cells ) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HeLa cells fixed with 4% paraformaldehyde (10 min)/permeabilized in 0.1% PBS-Tween used under the same conditions.

References for Anti-RNase L antibody [2E9] (ab13825)

This product has been referenced in:

  • Fabre O  et al. RNase L controls terminal adipocyte differentiation, lipids storage and insulin sensitivity via CHOP10 mRNA regulation. Cell Death Differ : (2012).Read more (PubMed: 22441668) »
  • Cockman ME  et al. Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins. Mol Cell Proteomics 8:535-46 (2009). WB; Human.Read more (PubMed: 18936059) »

See all 7 publications for this product

Publishing research using ab13825? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"